Significados de thrombophilia en inglés

Conclusions: Inherited thrombophilia is associated with an increased risk of upper-extremity DVT.

Additional considerations regarding HT choice include thrombotic risk and disorders associated with thrombophilia.

Objective: To determine to what extent adverse pregnancy outcomes are associated with thrombophilia.

Thus, at present, universal screening for thrombophilia in pregnancy cannot be justified clinically.

Oral contraceptives increase the risk only when combined with inherited thrombophilia.

Our aim was to determine the incidence of thrombophilia in children with CF.

Systemic autoimmune and connective tissue diseases and thrombophilia were excluded.

Similar findings were observed considering only heritable thrombophilia.

Background and objective: Patients with malignant tumor are at high risk of thrombophilia, which contributes to thromboembolism.

Our findings confirm that women with thrombophilia are at risk of developing VTE and complications in pregnancy.

Prevention may consist of either accurate pretransplantation screening for thrombophilia or identification of patients at higher DVT risk.

All patients underwent a thrombophilia study.

In a tertiary pediatric CF center, blood was screened for thrombophilia at annual review, and retested if abnormal.

Further studies are clearly needed before Rivaroxaban can be recommended as a standard treatment in patients with inherited thrombophilia.

There are no reports of an identified association of heritable thrombophilia with CF, although individual cases have been recognized.

This case report shows the efficacy and superiority of Rivaroxaban over traditional anticoagulants in the treatment of hereditary thrombophilia.